ASPIRE BIOPHARMA HOLDINGS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) reported Adjustments to Additional Paid in Capital, Warrant Issued of $14.64 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-11.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-03-11
- ASPIRE BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $14.64M.
- ASPIRE BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $14.64M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2022-12-31 | $14.64M 10-K · filed 2024-03-11 | |
| 2022-03-31 | $14.64M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |